{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:14:06Z","timestamp":1788261246548,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Late preterm and early term infants are a large proportion of all births. Historically, outcomes were thought to be similar to those of full term infants, but recent evidence demonstrates worse outcomes. Although serious morbidity is less common than in very preterm infants, the impact of modest illness in large numbers of more mature neonates is significant, with 30\u201340% requiring neonatal unit (NNU) admission, primarily for respiratory disease. The SurfON trial aims to evaluate whether early surfactant therapy improves outcomes compared with expectant management in late preterm and early term infants with respiratory distress. The primary objectives are to compare neonatal hospital stay and incidence of severe respiratory failure, with secondary objectives assessing other perinatal outcomes and cost-effectiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The SurfON trial is a multicentre, open-label, randomised controlled trial involving 45 UK NNUs, aiming to recruit 1522 infants over 30\u00a0months. Eligible infants are those born at 34\n                      <jats:sup>+0<\/jats:sup>\n                      to 38\n                      <jats:sup>+6<\/jats:sup>\n                      \u00a0weeks\u2019 gestation who require noninvasive respiratory support for respiratory distress within 24\u00a0h of birth. Infants are randomised in a 1:1 allocation ratio to either early surfactant therapy or expectant management. Infants randomised to the early surfactant therapy group will receive a single dose of CUROSURF\n                      <jats:sup>\u00ae<\/jats:sup>\n                      , a natural animal-derived surfactant. IMP administration reflects local site policy and procedure and may be completed by any clinician for whom this falls within their usual scope of practice, following confirmation of eligibility. The IMP is a commonly used drug in neonates and is being used in line with standard care. Side effects are uncommon and usually transient. Timing and dosage of IMP administration will be collected. Surfactant is a stock drug for all NNUs and will be administered and accounted for as per local practice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Evidence-based guidance for the management of late preterm and early term infants is sparse, and no previous large randomised controlled trials have focused on this population. Management of respiratory distress in late preterm and early term infants varies. Some clinicians prefer early surfactant administration to prevent deterioration\u201478others delay treatment to avoid mechanical ventilation. This inconsistency highlights the need for trials to establish an evidence base. Unexpected neonatal morbidity and prolonged hospitalisation cause significant psychological distress for families, impacting breastfeeding and maternal well-being. High intensive care workload and associated costs pose challenges for the NHS (National Health Service). Evidence-based management could improve outcomes and reduce healthcare burdens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      ISRCTN 15915394. Registered on 20th February 2020\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/www.isrctn.com\/ISRCTN15915394\" ext-link-type=\"uri\">https:\/\/www.isrctn.com\/ISRCTN15915394<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-025-09271-1","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T08:33:24Z","timestamp":1764578004000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["SurfON trial: study protocol for a multicentre, open-label, randomised controlled trial of early surfactant therapy versus expectant management in late preterm and early term infants with respiratory distress"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5038-3148","authenticated-orcid":false,"given":"Elaine M.","family":"Boyle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasha","family":"Bari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Hubbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund","family":"Juszczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Stenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Sweet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Bowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pollyanna","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Linsell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indrani","family":"Manoharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M.","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Rivero-Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Roehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayleigh","family":"Stanbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Wiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"issue":"4","key":"9271_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00431-014-2415-2","volume":"174","author":"RG Gijtenbeek","year":"2015","unstructured":"Gijtenbeek RG, Kerstjens JM, Reijneveld SA, Duiverman EJ, Bos AF, Vrijlandt EJ. RSV infection among children born moderately preterm in a community-based cohort. Eur J Pediatr. 2015;174(4):435\u201342.","journal-title":"Eur J Pediatr"},{"issue":"4","key":"9271_CR2","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1001\/jama.2010.1015","volume":"304","author":"JU Hibbard","year":"2010","unstructured":"Hibbard JU, Wilkins I, Sun L, Gregory K, Haberman S, Hoffman M, et al. Respiratory morbidity in late preterm births. JAMA. 2010;304(4):419\u201325.","journal-title":"JAMA"},{"issue":"1","key":"9271_CR3","doi-asserted-by":"publisher","first-page":"e20170266","DOI":"10.1542\/peds.2017-0266","volume":"140","author":"T Isayama","year":"2017","unstructured":"Isayama T, Lewis-Mikhael AM, O\u2019Reilly D, Beyene J, McDonald SD. Health services use by late preterm and term infants from infancy to adulthood: a meta-analysis. Pediatrics. 2017;140(1):e20170266.","journal-title":"Pediatrics"},{"issue":"8","key":"9271_CR4","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1177\/0009922809340432","volume":"48","author":"R Kitsommart","year":"2009","unstructured":"Kitsommart R, Janes M, Mahajan V, Rahman A, Seidlitz W, Wilson J, et al. Outcomes of late preterm infants: a retrospective, single-center, Canadian study. Clin Pediatr (Phila). 2009;48(8):844\u201350.","journal-title":"Clin Pediatr (Phila)"},{"issue":"2","key":"9271_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.siny.2012.01.004","volume":"17","author":"SJ Kotecha","year":"2012","unstructured":"Kotecha SJ, Dunstan FD, Kotecha S. Long term respiratory outcomes of late preterm-born infants. Semin Fetal Neonatal Med. 2012;17(2):77\u201381.","journal-title":"Semin Fetal Neonatal Med"},{"key":"9271_CR6","first-page":"49","volume":"19","author":"SJ Kotecha","year":"2016","unstructured":"Kotecha SJ, Gallacher DJ, Kotecha S. The respiratory consequences of early term birth and delivery by caesarean sections. Paediatr Respir Rev. 2016;19:49\u201355.","journal-title":"Paediatr Respir Rev"},{"issue":"11","key":"9271_CR7","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/ppul.23448","volume":"51","author":"SJ Kotecha","year":"2016","unstructured":"Kotecha SJ, Watkins WJ, Lowe J, Henderson AJ, Kotecha S. Effect of early term birth on respiratory symptoms and lung function in childhood and adolescence. Pediatr Pulmonol. 2016;51(11):1212\u201321.","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"9271_CR8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/thoraxjnl-2011-200329","volume":"67","author":"SJ Kotecha","year":"2012","unstructured":"Kotecha SJ, Watkins WJ, Paranjothy S, Dunstan FD, Henderson AJ, Kotecha S. Effect of late preterm birth on longitudinal lung spirometry in school age children and adolescents. Thorax. 2012;67(1):54\u201361.","journal-title":"Thorax"},{"issue":"7","key":"9271_CR9","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1136\/thorax-2022-218931","volume":"78","author":"C Crump","year":"2022","unstructured":"Crump C, Sundquist J, Sundquist K. Preterm or early term birth and long-term risk of asthma into midadulthood: a national cohort and cosibling study. Thorax. 2022;78(7):653\u201360.","journal-title":"Thorax"},{"key":"9271_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1824-7288-40-52","volume":"40","author":"M Natile","year":"2014","unstructured":"Natile M, Ventura ML, Colombo M, Bernasconi D, Locatelli A, Plevani C, et al. Short-term respiratory outcomes in late preterm infants. Ital J Pediatr. 2014;40:52.","journal-title":"Ital J Pediatr"},{"issue":"3","key":"9271_CR11","doi-asserted-by":"publisher","first-page":"265 e1","DOI":"10.1016\/j.ajog.2014.03.021","volume":"211","author":"LI Parikh","year":"2014","unstructured":"Parikh LI, Reddy UM, Mannisto T, Mendola P, Sjaarda L, Hinkle S, et al. Neonatal outcomes in early term birt. Am J Obstet Gynecol. 2014;211(3):265 e1-e11.","journal-title":"Am J Obstet Gynecol"},{"key":"9271_CR12","doi-asserted-by":"publisher","unstructured":"Robinson S, Seaton S, Matthews RJ, Johnson S, Draper ES, Manktelow B, et al., editors. Respiratory outcomes in late and moderately preterm infants: results from a population-based study. Selected abstracts of the 1st Congress of joint European Neonatal Societies (jENS 2015); September 16\u201320, 2015; Budapest (Hungary). Session \u201cepidemiology\u201d. J Pediatr Neonat Individual Med. 2015;4(2):e040208. https:\/\/doi.org\/10.7363\/040208.","DOI":"10.7363\/040208"},{"issue":"4","key":"9271_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1001\/jama.2010.1015","volume":"304","author":"JU Hibbard","year":"2010","unstructured":"Consortium on Safe L, Hibbard JU, Wilkins I, Sun L, Gregory K, Haberman S, et al. Respiratory morbidity in late preterm birth. JAMA. 2010;304(4):419\u201325.","journal-title":"JAMA"},{"issue":"4","key":"9271_CR14","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.clp.2013.07.004","volume":"40","author":"AD Mahoney","year":"2013","unstructured":"Mahoney AD, Jain L. Respiratory disorders in moderately preterm, late preterm, and early term infants. Clin Perinatol. 2013;40(4):665\u201378.","journal-title":"Clin Perinatol"},{"issue":"8","key":"9271_CR15","first-page":"SC09","volume":"11","author":"S Deshpande","year":"2017","unstructured":"Deshpande S, Suryawanshi P, Ahya K, Maheshwari R, Gupta S. Surfactant therapy for early onset pneumonia in late preterm and term neonates needing mechanical ventilatio. J Clin Diagn Res. 2017;11(8):SC09-SC12.","journal-title":"J Clin Diagn Res"},{"issue":"11","key":"9271_CR16","first-page":"CD001456","volume":"11","author":"FL Bahadue","year":"2012","unstructured":"Bahadue FL, Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrom. Cochrane Database Syst Rev. 2012;11(11):CD001456.","journal-title":"Cochrane Database Syst Rev"},{"key":"9271_CR17","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1038\/sj.jp.7211320","volume":"25 Suppl 2","author":"GK Suresh","year":"2005","unstructured":"Suresh GK, Soll RF. Overview of surfactant replacement trials. J Perinatol. 2005;25 Suppl 2:S40\u20134.","journal-title":"J Perinatol"},{"issue":"6","key":"9271_CR18","doi-asserted-by":"publisher","first-page":"F479","DOI":"10.1136\/archdischild-2014-307347","volume":"100","author":"EM Boyle","year":"2015","unstructured":"Boyle EM, Johnson S, Manktelow B, Seaton SE, Draper ES, Smith LK, et al. Neonatal outcomes and delivery of care for infants born late preterm or moderately preterm: a prospective population-based study. Arch Dis Child Fetal Neonatal Ed. 2015;100(6):F479\u201385.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"9271_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.siny.2018.09.001","volume":"24","author":"M Delnord","year":"2019","unstructured":"Delnord M, Zeitlin J. Epidemiology of late preterm and early term births - an international perspective. Semin Fetal Neonatal Med. 2019;24(1):3\u201310.","journal-title":"Semin Fetal Neonatal Med"},{"issue":"10","key":"9271_CR20","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1080\/14767058.2017.1313828","volume":"31","author":"C Dani","year":"2018","unstructured":"Dani C, Mosca F, Vento G, Tagliabue P, Picone S, Lista G, et al. Effects of surfactant treatment in late preterm infants with respiratory distress syndrome. J Matern Fetal Neonatal Med. 2018;31(10):1259\u201366.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"5","key":"9271_CR21","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.jval.2012.02.008","volume":"15","author":"B van Hout","year":"2012","unstructured":"van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15(5):708\u201315.","journal-title":"Value Health"},{"key":"9271_CR22","unstructured":"National Institute for Health and Care Excellence. NICE health technology evaluations: the manual. Process and methods [PMG36]. 2022. Available from: https:\/\/www.nice.org.uk\/process\/pmg36\/chapter\/committee-recommendations. Accessed 23 Jul 2024."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09271-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09271-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09271-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T14:02:23Z","timestamp":1767708143000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-025-09271-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9271"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09271-1","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"8 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The SurfON trial received approval from the MHRA and the NHS Health Research Authority (REC Ref: 20\/EM\/0003) and the East Midlands Derby Research Ethics Committee. Parents of eligible infants receive verbal and written information, including a parent information leaflet. Those with legal parental responsibility are approached to discuss the trial, address questions, and obtain informed consent. Parents are given sufficient time to consider the information and may consult the research team or independent parties before deciding to participate. Informed consent must be obtained by a qualified study team member. Parents must personally sign and date the latest approved version of the informed consent form before any study-specific procedures are conducted. Non-English-speaking parents must have an interpreter available to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable \u2014 no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent form are available from the corresponding author on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"P. H. is a member of the NIHR Health Technology Assessment Funding Committee (commissioning). P. H. also presented at a Scottish Neonatal Workshop funded by Cheisi Pharmaceuticals. D. G. S. has received honoraria in the past from Chiesi Pharmaceuticals for lecturing. C. C. R. has accepted speakers\u2019 honoraria and consultation fees for educational activities initiated and promoted by Chiesi Pharmaceuticals, Parma, Italy. E. M. B. has accepted speakers\u2019 honoraria and consultation fees for educational activities initiated and promoted by Chiesi Pharmaceuticals, Parma, Italy. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"5"}}